Ado-trastuzumab emtansine and Omalizumab Subcutaneous
Determining the interaction of Ado-trastuzumab emtansine and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Ombitasvir, Paritaprevir, and Ritonavir
- Ado-trastuzumab emtansine-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Ado-trastuzumab emtansine-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Ado-trastuzumab emtansine-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Ado-trastuzumab emtansine-Omeclamox-Pak
- Ado-trastuzumab emtansine-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Ado-trastuzumab emtansine Intravenous
- Omalizumab Subcutaneous-Adox Pak 2/100
- Omalizumab Subcutaneous-Adoxa
- Omalizumab Subcutaneous-Adoxa CK
- Omalizumab Subcutaneous-Adoxa Pak
- Omalizumab Subcutaneous-Adoxa Pak 1/100